Roble, Belko & Company, Inc Abbott Laboratories Transaction History
Roble, Belko & Company, Inc
- $763 Million
- Q4 2025
A detailed history of Roble, Belko & Company, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Roble, Belko & Company, Inc holds 549 shares of ABT stock, worth $71,386. This represents 0.01% of its overall portfolio holdings.
Number of Shares
549
Previous 549
-0.0%
Holding current value
$71,386
Previous $74,000
6.76%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding ABT
# of Institutions
3,643Shares Held
1.39BCall Options Held
10.2MPut Options Held
8.93M-
Vanguard Group Inc Valley Forge, PA176MShares$22.8 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.2MShares$10.2 Billion0.37% of portfolio
-
Capital International Investors Los Angeles, CA61.6MShares$8.01 Billion1.4% of portfolio
-
Capital Research Global Investors Los Angeles, CA38.8MShares$5.04 Billion1.02% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $228B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...